Related Experiment Video
Updated: May 27, 2025

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[What is new in pediatric rheumatological diseases?]
Manel Mejbri1, Aikaterini Koryllou2, Géraldine Blanchard-Rohner1
1Unité d'immunologie-vaccinologie-rhumatologie pédiatrique, Service de pédiatrie générale, Département de la femme, de l'enfant et de l'adolescent, Hôpitaux universitaires de Genève, 1211 Genève 14.
Insights
Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are complex pediatric rheumatologic diseases. Advances in biotherapy and genetics offer more targeted treatments for JIA, SLE, vasculitis, and immune deficiencies.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Genetics
Context:
- Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are complex pediatric rheumatologic conditions.
- These diseases have significant genetic components and present diagnostic and therapeutic challenges.
- Related conditions include pediatric systemic vasculitis and immune deficiencies linked to dysimmunity.
Purpose:
- To explore various aspects of JIA and SLE.
- To discuss pediatric systemic vasculitis and associated immune deficiencies.
- To highlight recent advancements in understanding and treating these pediatric autoimmune and immune-related disorders.
Summary:
- JIA and SLE are intricate pediatric autoimmune diseases with genetic underpinnings.
- Biotherapy and genetic research have transformed treatment approaches.
- The article reviews JIA, SLE, pediatric vasculitis, and immune deficiencies, emphasizing therapeutic progress.
Impact:
- Provides an overview of complex pediatric rheumatologic and immune disorders.
- Highlights the impact of genetic research and biotherapy on patient outcomes.
- Informs clinicians and researchers about the latest developments in diagnosis and treatment for pediatric autoimmune diseases.
Abstract:
Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are complex pediatric rheumatologic diseases with a significant genetic component. These conditions include various subtypes, each of which presents unique diagnostic and therapeutic challenges. Recent advances in biotherapy and genetics have revolutionized the management of these diseases, allowing for more targeted and effective treatments. This article explores the different aspects of JIA and SLE, as well as pediatric systemic vasculitis and certain immune deficiencies associated with dysimmunity, and highlights recent progress in the understanding and treatment of these diseases.
More Related Videos
06:31Author Spotlight: Enhancing Rheumatoid Arthritis Research Through HR-pQCT Imaging Analysis
Published on: October 6, 2023
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...